Results 101 to 110 of about 37,681 (214)

Early‐Onset Prostate Cancer: Epidemiology, Risk Factors, Biology, Clinical Features, Management, and Early Detection

MedComm, Volume 7, Issue 8, August 2026.
EOPC is a distinct clinicopathological entity separable from SOPC, differing fundamentally in genetic susceptibility, TMPRSS2:ERG fusion frequency, and survival outcomes. Although research remains nascent, this review provides the first comprehensive synthesis of current evidence, offering a critical foundation to guide future investigations into this ...
Xingyu Xiong, Weizhen Zhu, Weichao Huang, Shiyu Zhang, Qi Deng, Jie Yang, Hang Xu, Qiang Wei, Lu Yang   +8 more
wiley   +1 more source

In‐Depth optimization and characterization of prostatic and penile vessel imaging with Ferumoxytol‐enhanced magnetic resonance imaging

Medical Physics, Volume 53, Issue 8, August 2026.
Abstract Background Vasculogenic erectile dysfunction (ED) arises from impairment of the vascular supply to the penis and requires reliable quantitative imaging for diagnosis, management, and longitudinal monitoring, particularly after pelvic surgery or radiotherapy.
Darren Fang, Justin McWIlliams, Christina Wang, Danilo Maziero, Keisuke S. Iwamoto, Amar U. Kishan, J. Paul Finn, Xiaodong Zhong, Dan Ruan   +8 more
wiley   +1 more source

Developing appropriate criteria for Benign Prostatic Hyperplasia Surgery Using RAND Appropriateness Method (RAM)

Armaghane Danesh Bimonthly Journal, 2009
: Introduction & Objective: Results of different studies show that a relatively large number of healthcare services offered are inappropriate or unnecessary. Benign prostatic hyperplasia is a benign enlargement of the prostate gland.
R Ostovar, A Pourreza, A Rashidian, S Mehrabi, AR Mehrsay, M Mahmoodi, H Eftekhar Ardabili, GH Poormand   +7 more
doaj  

Targeting fibrosis in the treatment of lower urinary tract dysfunction

The Journal of Pathology, Volume 269, Issue 4-5, Page 493-503, August 2026.
Abstract Benign prostatic hyperplasia (BPH) is a widely prevalent age‐associated disease that is the main contributor to lower urinary tract dysfunction (LUTD) in aging men. Although prostate fibrosis has been recognized as a contributor to BPH pathophysiology, there are not any clinically available therapeutics that target this aspect of disease ...
Ajinkya R Limkar, Sophia M Vrba, Emily A Ricke, Zsuzsanna Fabry, Matthew S Lee, Kevin T McVary, William A Ricke   +6 more
wiley   +1 more source

Massive Benign Prostatic Hyperplasia [PDF]

Journal of the Royal Society of Medicine, 1987
D A, Tolley, P J, English, K M, Grigor
openaire   +2 more sources

Association Between Kamikihito Treatment and Nocturnal Voiding Frequency in Patients With Sleep Disturbance: A Retrospective Clinical Study

Traditional &Kampo Medicine, Volume 13, Issue 2, August 2026.
ABSTRACT Aim Sleep disturbance is an important contributing factor to nocturia, particularly in older adults. Kamikihito is a Kampo medicine traditionally prescribed for the Heart and spleen systems deficiency pattern (TM1). The aim of this study was to retrospectively evaluate the association between kamikihito treatment and nocturnal voiding ...
Shigehisa Kubota, Masayuki Nagasawa, Akinori Wada, Kenichi Kobayashi, Kazuaki Yamanaka, Tetsuya Yoshida, Kazuyoshi Johnin, Susumu Kageyama   +7 more
wiley   +1 more source

Association Between Trial Duration and Completion Rate in Men's Health Clinical Trials, 2005–2024

Trends in Urology &Men's Health, Volume 17, Issue 4, August 2026.
ABSTRACT Clinical trials drive evidence generation in men's health, yet temporal patterns in trial duration and completion remain poorly characterized. We examined relationships between trial duration, completion rates, and trial characteristics in men's health research registered over two decades.
Thriaksh Rajan, Mahan Miryala, Thomas Syphan, Kyle Scarberry, Adonis Hijaz, Ramy Abou Ghayda   +5 more
wiley   +1 more source

Ejaculatory Dysfunction and Minimally Invasive Surgical Treatments (MIST) for Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement

Trends in Urology &Men's Health, Volume 17, Issue 4, August 2026.
ABSTRACT While transurethral resection of the prostate (TURP) is considered the standard surgical treatment in symptomatic benign prostatic enlargement (BPE) secondary to benign prostatic hyperplasia (BPH), it is not without surgical morbidities and has adverse impact on various sexual function domains such as ejaculatory dysfunction (EjD) and erectile
Haijun Yao, Tao Wang, Shan‐Chao Zhao, Lei Zheng, Rui Jiang, Han Wu, Jingjing Gao, Baibing Yang, Yuzhuo Yang, Haocheng Lin, Eric Chung   +10 more
wiley   +1 more source

Assessment and Modeling of the Relationship Between Age, Prostate Volume, and Prostate‐Specific Antigen in a Population of Men From Sub‐Saharan Africa With a Low Risk of Prostate Cancer

Trends in Urology &Men's Health, Volume 17, Issue 4, August 2026.
ABSTRACT PSA levels are influenced by several non‐tumor‐related factors, including age and prostate volume (PV). However, data on the relationships between these parameters in sub‐Saharan African populations remain limited. To assess and quantify the associations between age, PV, and PSA in Congolese men with a low probability of prostate cancer (PCa).
Ghidmar Onguélé‐Okemba, Yannick Ijosdi Dimi Nyanga, Steve Aristide Ondziel Opara, Roland Bertile Banga‐Mouss, Christ Albertin Obongha Ondzé Oponguy, Jesvy Naasson Mayala, Nemrod Lazarel Ekouya Oba, Anani Wencesl Severin Odzébé, Prosper Alain Bouya   +8 more
wiley   +1 more source

Prostate cancer diagnosis using plasma extracellular vesicles isolated via aqueous two‐phase systems

VIEW, Volume 7, Issue 4, August 2026.
Abstract Prostate cancer (PCa) is the second most prevalent cancer in men, with early detection and precise staging remaining critical for improving outcomes. While PSA tests and biopsies are widely used, they suffer from low specificity and often lead to unnecessary procedures.
Yongmin Kwon, Minyeob Lim, Suyeon Kim, Youngju Seo, Meeyoung Kim, Jiyoul Lee, Jaesung Park   +6 more
wiley   +1 more source